PubRank

Christer Busch

Author PubWeight™ 76.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005 16.35
2 Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011 13.30
3 A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002 10.64
4 Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014 10.06
5 Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 2008 8.62
6 Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005 3.40
7 Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993). Eur Urol 2010 1.52
8 No increased prostate cancer incidence after negative transrectal ultrasound guided multiple biopsies in men with increased prostate specific antigen and/or abnormal digital rectal examination. J Urol 2003 1.39
9 Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int 2008 1.37
10 Blind color decomposition of histological images. IEEE Trans Med Imaging 2013 1.06
11 The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev 2010 1.02
12 Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium. Virchows Arch 2003 1.00
13 Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma. Int J Cancer 2010 0.99
14 Low-grade Ta (noninvasive) urothelial carcinoma of the bladder. Urology 2005 0.92
15 Personalized prediction of tumor response and cancer progression on prostate needle biopsy. J Urol 2009 0.89
16 COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67. Cancer Epidemiol 2010 0.86
17 The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer. Scand J Urol Nephrol 2005 0.83
18 A fluid cover medium provides superior morphology and preserves RNA integrity in tissue sections for laser microdissection and pressure catapulting. J Pathol 2004 0.82
19 Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma. Virchows Arch 2014 0.80
20 Tumour expression of bladder cancer-associated urinary proteins. BJU Int 2013 0.79
21 Prediction of the volume of large prostate cancers by multiple core biopsies. Scand J Urol Nephrol 2005 0.79
22 Pro-apoptotic effect of aurothiomalate in prostate cancer cells. Cell Cycle 2009 0.77
23 Histological stain evaluation for machine learning applications. J Pathol Inform 2013 0.75
24 Simplification of grading papillary urothelial neoplasia using a reduced set of diagnostic features. Anal Quant Cytol Histol 2011 0.75
25 Diagnosis of intraurothelial neoplasia. Interobserver variation and the value of individual histopathologic attributes. Anal Quant Cytol Histol 2011 0.75
26 Prediction of percent Gleason grade 4/5 by multiple core biopsies. Scand J Urol Nephrol 2006 0.75
27 Microarray core detection by geometric restoration. Anal Cell Pathol (Amst) 2012 0.75